Candida Summit

Candida Summit

Tuesday, August 14, 2012


Because the brain dead sheeple aren't getting it yet?  Have to post this, until they do.

With no recorded cases of hepatitis B among infants and children of commonly healthy mothers, the question MUST be asked by any clear thinking person why most states now mandate and or coerce parents into vaccinating their infants and children with a serum created largely for prostitutes and promiscuous male homosexuals?

A vaccine with the full extent of it's horrific side effects remain largely unknown because there has not been or is currently a single case of scientific medical research into the true side effects of this vaccine given to innocent new born babies, again, a vaccine designed for prostitutes and promiscuous male homosexuals!

While known rates of MS, asthma, SIDS, Cancer, Heart Disease and other afflictions have been increasing in children and have been linked to hepatitis B vaccinations, the full extent of its gross and subtle effects on injected children will never be known for many, many decades–if ever, because no science or medical research is being done ON THIS INSANE VACCINE GIVEN TO INNOCENT BABIES!!

Today millions of infants are being IGNORANTLY injected, allegedly for their own good, with a sexual prophylactic, toxic in its natural form DISEASE RIDDLED, DISEASE CAUSING VACCINES. Who are these INSANE injections designed to protect, for sure not our babies? DO YA THINK MAYBE NOW IT'S TIME TO WAKE UP??

Ian Larsen Gromowski.    

Remember why so many "Christians" kept a blind eye during the Holocaust... it was not happening to them.  

* There seems to be nothing on the site as the content is always being taken down, or perhaps hacked.

Baby Ian did pass away.
I know that his website keeps getting shut down, the medical community does not want people to see this. You can learn more just by googling: Baby Ian Hep B Vaccine.   I found the story here. As painful as it is--I can't stop crying--I think people need to see this so they see what vaccines are doing to our children. So tragic and completely unnecessary. Wake up, stupid people!
Ken O'Toole ‎" This was the last time I was able to hold Ian. I held him for two hours. Ian fell asleep in my arms. I will hold this particular memory in my heart forever. My son looked me in the eyes and fell asleep in the comfort and warmth of my arms. Nothing could ever replace that feeling." Deanna Gromowski

Wise Up Journal - » Baby Ian’s brave struggle with the Hepatitis B vaccine *  

The post refers to little Ian Gromowski, who was murdered with a "routine vaccination". Yes, it was murder in the 3rd degree. (Manslaughter) Nobody went to prison, while the pharmaceutical companies are defending legislation to "fast track" future poisons. seems to be out of service, but a search for Ian's name via will produce the details.  


Two of the Hep B vaccine package insert (prescribing information) DIRECTLY from the pHARMa companies ADMITTING that their product/s CAUSE disease.  So by all means, don't take my word for it.  
Pages 9-10  
Injection Site Reactions: Pain/tenderness/soreness, swelling/induration, erythema; Body as a Whole:  Fever; Digestive System: Anorexia, diarrhea, vomiting; Nervous System/Psychiatric: Irritability, somnolence, crying; Respiratory System: Upper respiratory infection, rhinorrhea, cough, rhinitis; Skin: Rash; Special Senses: Otitis media.

Post-Marketing Experience

As with any vaccine, there is the possibility that broad use of COMVAX could reveal adverse experiences not observed in clinical trials. The following additional adverse reactions have been reported with the use of the marketed vaccine.

Anaphylaxis, angioedema, urticaria, erythema multiforme


Nervous System
Seizure, febrile seizures

Potential Adverse Effects

In addition, a variety of adverse effects have been reported with marketed use of either PedvaxHIB or RECOMBIVAX HB in infants and children through 71 months of age. These adverse effects are listed below.


Sterile injection-site abscess; pain at the injection site

Symptoms of hypersensitivity including reports of rash, pruritus, edema, arthralgia, dyspnea, hypotension, and ecchymoses

Cardiovascular System
Tachycardia; syncope

Digestive System
Elevation of liver enzymes

Increased erythrocyte sedimentation rate

Musculoskeletal System

Nervous System
Bell's Palsy; Guillain-Barré Syndrome

Agitation; somnolence; irritability

Stevens-Johnson Syndrome; alopecia

Special Senses
Conjunctivitis; visual disturbances

Adverse Event Reporting
Patients, parents and guardians should be instructed to report any serious adverse reactions to their health-care provider who in turn should report such events to the U.S. Department of Health and Human Services through the Vaccine Adverse Event Reporting System (VAERS), 1-800-822-7967. The healthcare provider should inform the parent or guardian of the National Vaccine Injury Compensation Program (NVICP), 1-800-338-2382.
Pages 6-8


6.1 Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trials of another vaccine and may not reflect the rates observed in practice.

The most common solicited adverse events were injection site soreness (22%) and fatigue (14%).

In 36 clinical studies, a total of 13,495 doses of ENGERIX-B were administered to 5,071 healthy adults and children who were initially seronegative for hepatitis B markers, and healthy neonates. All subjects were monitored for 4 days post-administration. Frequency of adverse events tended to decrease with successive doses of ENGERIX-B.

Using a symptom checklist, the most frequently reported adverse events were injection site soreness (22%) and fatigue (14%). Other events are listed below. Parent or guardian completed forms for children and neonates. Neonatal checklist did not include headache, fatigue, or dizziness.

Incidence 1% to 10% of Injections: Nervous System Disorders: Dizziness, headache.

General Disorders and Administration Site Conditions: Fever (>37.5°C), injection site erythema, injection site induration, injection site swelling.
Incidence  1% of Injections:  Infections and Infestations: Upper respiratory tract illnesses.

Blood and Lymphatic System Disorders: Lymphadenopathy.

Metabolism and Nutrition Disorders: Anorexia.

Psychiatric Disorders: Agitation, insomnia.

Nervous System Disorders: Somnolence, tingling.

Vascular Disorders: Flushing, hypotension.

Gastrointestinal Disorders: Abdominal pain/cramps, constipation, diarrhea, nausea, vomiting.

Skin and Subcutaneous Tissue Disorders: Erythema, petechiae, pruritus, rash, sweating, urticaria.

Musculoskeletal and Connective Tissue Disorders: Arthralgia, back pain, myalgia, pain/stiffness in arm, shoulder, or neck.

General Disorders and Administration Site Conditions: Chills, influenza-like symptoms, injection site ecchymosis, injection site pain, injection site pruritus, irritability, malaise, weakness.

6.2 Postmarketing Experience

In addition to reports in clinical trials, worldwide voluntary reports of adverse events received for ENGERIX-B since market introduction (1990) are listed below. This list includes serious adverse events or events which have a suspected causal connection to components of ENGERIX-B.

The following adverse events have been identified during postapproval use of ENGERIX-B. Because these events are reported voluntarily from a population of unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to the vaccine. [yeah right !!]

Infections and Infestations: Herpes zoster, meningitis.

Blood and Lymphatic System Disorders: Thrombocytopenia.

Immune System Disorders: Allergic reaction, anaphylactoid reaction, anaphylaxis. An apparent hypersensitivity syndrome (serum sickness-like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and ermatologic reactions such as urticaria, erythema multiforme, ecchymoses, and erythema  nodosum.

Nervous System Disorders: Encephalitis, encephalopathy, migraine, multiple sclerosis, neuritis, neuropathy including hypoesthesia, paresthesia, Guillain-Barré syndrome and Bell’s palsy, optic neuritis, paralysis, paresis, seizures, syncope, transverse myelitis.

Eye Disorders: Conjunctivitis, keratitis, visual disturbances.

Ear and Labyrinth Disorders: Earache, tinnitus, vertigo.

Cardiac Disorders: Palpitations, tachycardia.

Vascular Disorders: Vasculitis.

Respiratory, Thoracic and Mediastinal Disorders: Apnea, bronchospasm including asthma-like symptoms.

Gastrointestinal Disorders: Dyspepsia.

Skin and Subcutaneous Tissue Disorders: Alopecia, angioedema, eczema, erythema multiforme including Stevens-Johnson syndrome, erythema nodosum, lichen planus, purpura.

Musculoskeletal and Connective Tissue Disorders: Arthritis, muscular weakness.

General Disorders and Administration Site Conditions: Injection site reaction.

Investigations: Abnormal liver function tests.



Exemptions are freely available:               

No comments: